col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


79 Ergebisse       Seite 1

 [1] 
Publishing House RAMS: Bulletin of Experimental Biology and Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jan―09 Effect of the C12L, A35R, A40R, and A41L Genes of MVA Vector on the Immunogenicity of Recombinant MVA Expressing the SARS-CoV-2 Spike Protein O. V. Orlova, D. V. Glazkova, R. R. Mintaev, G. M. Tsyganova, N. F. Brazgun, G. A. Shipulin, E. V. Bogoslovskaya
2 [GO] 2026―Jan―08 An MVA-Based Vector Expressing the SARS-CoV-2 RBD Fused to N Protein Induces Neutralizing Antibodies and T-Cell Immune Response in Mice D. V. Glazkova, R. R. Mintaev, O. V. Orlova, B. V. Belugin, G. A. Shipulin, E. V. Bogoslovskaya
3 [GO] 2025―Sep―25 Production of Recombinant Nucleocapsid Protein SARSN1 and Its Use for Assessing the Immune Response in Mice after Vaccination with a Live Probiotic Vaccine Containing the Coronavirus Nucleocapsid Protein T. V. Gupalova, E. A. Bormotova, G. F. Leontieva, T. A. Kramskaya, Yu.A. Desheva, A. N. Suvorov
4 [GO] 2025―Aug―29 Immunogenicity of DNA Vaccines against COVID-19 That Encode B- and T-Cell Immunogens after Combined Injection M. B. Borgoyakova, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, E. V. Tigeeva, V. A. Yakovlev, et al. (+4)
5 [GO] 2025―Jul―31 Study of the activity of plant-based preparations aganst SARS-CoV-2 and herpes simplex virus type 2 in vitro: a review of experimental data E. I. Kazachinskaia, L. N. Zibareva, Y. V. Kononova, A. M. Shestopalov, M. I. Voevoda, A. A. Chepurnov
6 [GO] 2025―Jul―18 Differentiation of the Cytokine Profile Modified by SARS-CoV-2 and Influenza Virus in an In Vitro Experiment N. V. Zaitseva, K. G. Starkova, O. V. Dolgikh, V. B. Alekseev
7 [GO] 2025―Jun―04 An MVA-based vector expressing the SARS-CoV-2 RBD fused to N protein induces neutralizing antibodies and T-cell immune response in mice D. V. Glazkova, R. R. Mintaev, O. V. Orlova, B. V. Belugin, G. A. Shipulin, E. V. Bogoslovskaya
8 [GO] 2025―Mai―31 Analysis of Increased False-Positive ELISA Results for HIV in the Blood of Donors Infected with SARS-CoV-2 H. Lin, Z. Wang, Q. Ren, Z. Cai, F. Ge, W. Yuan, et al. (+5)
9 [GO] 2025―Mrz―27 Production of recombinant nucleocapsid protein SARSN1 and its use to assess the immune response after vaccination of mice with a live probiotic vaccine containing the nucleocapsid protein of coronavirus T. V. Gupalova, E. A. Bormotova, G. F. Leontieva, T. A. Kramskaya, Yu. A. Desheva, A. N. Suvorov
10 [GO] 2025―Feb―19 Immunogenicity of DNA vaccines against COVID-19, which encodes B and T cell immunogens with co-injection M. B. Borgoyakova, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, E. V. Tigeeva, V. A. Yakovlev, et al. (+4)
11 [GO] 2025―Jan―27 Differentiation of the cytokine profile modified by SARS-CoV-2 and Influenzavirus in an in vitro experiment N. V. Zaitseva, K. G. Starkova, O. V. Dolgikh, V. B. Alekseev
12 [GO] 2024―Dez―27 Analysis of increased false-positive ELISA results for HIV in blood of donors infected with SARS-CoV-2 H. Lin, Z. Wang, Q. Ren, Z. Cai, F. Ge, W. Yuan, et al. (+5)
13 [GO] 2024―Sep―28 Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov
14 [GO] 2024―Aug―02 Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2 E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, et al. (+5)
15 [GO] 2024―Jun―19 Correction to: Ratios between the Levels of IL-18, Free IL-18, and IL-18-Binding Protein Depending on the Severity and Outcome of COVID-19 A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
16 [GO] 2024―Jun―19 Factors of Interleukin-6 Signaling in COVID-19 Patients with Lung Damage of Varying Degrees: A Pilot Study A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev
17 [GO] 2024―Jun―19 Endothelin Level in Menopausal Women with Comorbidity of the Acute Phase Middle Severity COVID-19 with Arterial Hypertension and Type 2 Diabetes Mellitus N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, et al. (+2)
18 [GO] 2024―Jun―19 Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, et al. (+2)
19 [GO] 2024―Jun―19 Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, et al. (+6)
20 [GO] 2024―Mai―22 Relationship between HLA-II gene polymorphisms and immune response in COVID-19 survivors and volunteers vaccinated against this infection V. I. Dubrovina, D. D. Bryukhova, K. M. Korytov, A. B. Pyatidesyatnikova, V. A. Vishnyakov, S. V. Balakhonov
21 [GO] 2024―Mrz―15 Ratios between the Levels of IL-18, Free IL-18, and IL-1β-Binding Protein Depending on the Severity and Outcome of COVID-19 A. A. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
22 [GO] 2024―Mrz―15 Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19 K. K. Jekebekov, A. S. Nurpeisova, Zh.S. Abay, K. A. Shorayeva, Zh.S. Absatova, R. T. Abitayev, et al. (+10)
23 [GO] 2024―Feb―29 Use of adjuvant compositions based on squalene ensures the induction of neutralizing antibodies against SARS-CoV-2 E. A. Volosnikova, N. V. Volkova, V. V. Ermolaev, M. B. Borgoyakova, V. S. Nesmeyanova, A. V. Zaykovskaya, et al. (+5)
24 [GO] 2024―Feb―12 Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen) K. G. Starkova, O. V. Dolgikh, I. N. Alikina, O. A. Kazakova, N. A. Nikonoshina, V. B. Alekseev
25 [GO] 2024―Jan―09 Analysis of the Morphology of Monocytes and Lymphocytes from COVID-19 Patients Using Low-Voltage Scanning Electronic Microscopy A. A. Velmiskina, Yu. V. Nikitin, V. Yu. Mikhailovskii, S. V. Mosenko, A. Yu. Anisenkova, S. V. Apalko, et al. (+6)
26 [GO] 2024―Jan―08 Features of Distribution of the Allelic Variant of the OAS1 Gene Associated with Severe Form of the Coronavirus Infection in the Russian and Global Populations M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov
27 [GO] 2023―Dez―29 Factors of interleukin 6 signalling in COVID-19 patients with varied degree of lung injury: a pilot study А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, D. T. Kuchiev, N. V. Gomyranova, F. N. Paleev
28 [GO] 2023―Dez―29 Endothelin level in climacteric women with comorbidity of the acute phase middle severity COVID-19 with arterial hypertension and type 2 diabetes mellitus N. V. Semenova, E. V. Vyrupaeva, S. I. Kolesnikov, O. A. Nikitina, L. V. Rychkova, M. A. Darenskaya, et al. (+2)
29 [GO] 2023―Dez―29 Analysis of T-cell and humoral immune response to SARS-CoV-2 antigens in vaccinized combined vector vaccine "Gam-COVID-Vac" in rheumatoid arthritis patients taking rituximab V. O. Omelchenko, Yu. D. Kurochkina, A. V. Fedorova, V. S. Ovchinnikov, V. V. Koval, I. V. Bratko, et al. (+2)
30 [GO] 2023―Dez―29 Delivery of experimental mRNA vaccine, encoding the RBD of SARS-CoV-2 using jet injection D. N. Kisakov, L. A. Kisakova, S. V. Sharabrin, V. A. Yakovlev, E. V. Tigeeva, M. B. Borgoyakova, et al. (+6)
31 [GO] 2023―Nov―18 Artificial COVID-19 T-Cell Immunogen M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, et al. (+4)
32 [GO] 2023―Nov―03 Ratios between the levels of interleukin 18, free interleukin 18 and interleukin 18 binding protein depending on severity and outcome of COVID-19 А. А. Korotaeva, E. V. Samoilova, N. V. Pogosova, A. G. Fesenko, S. V. Evchenko, F. N. Paleev
33 [GO] 2023―Nov―03 Safety assessment: a comparative analysis of bacterial endotoxin quantitative content and pyrogenicity determination of the Kazakhstan vaccine QazCovid-in® against COVID-19 K. K. Dzhekebekov, A. S. Nurpeisova, Zh. S. Abai, K. A. Shoraeva, Zh. S. Absatova, R. T. Abitaev, et al. (+10)
34 [GO] 2023―Okt―20 Ultrastructural Reorganization of Endotheliocytes of Pulmonary Blood Capillaries in COVID-19 N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin
35 [GO] 2023―Aug―30 Distribution features of the OAS1 gene allelic variant associated with a severe form of the coronavirus infection in the Russian and global populations M. V. Olkova, S. M. Koshel, V. S. Petrushenko, A. A. Alimov
36 [GO] 2023―Jul―19 The Search for Single-Domain Antibodies Interacting with the Receptor-Binding Domain of SARS-CoV-2 Surface Protein V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, et al. (+7)
37 [GO] 2023―Jun―28 Artificial COVID-19 T-cell immunogen M. B. Borgoyakova, L. I. Karpenko, A. P. Rudometov, E. V. Starostina, A. M. Zadorozhny, L. A. Kisakova, et al. (+4)
38 [GO] 2023―Jun―19 KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into Cells E. N. Knyazev, R. S. Kalinin, V. A. Abrikosova, Yu.A. Mokrushina, S. A. Tonevitskaya
39 [GO] 2023―Jun―01 Ultrastructural reorganization endotheliocytes of pulmonary blood capillaries in COVID-19 N. P. Bgatova, S. V. Savchenko, A. N. Lamanov, M. Zh. Ergazina, M. T. Adilova, A. Yu. Letyagin
40 [GO] 2023―Mrz―11 SARS-CoV-2 Mutations Lead to a Decrease in the Number of Tissue-Specific MicroRNA-Binding Regions in the Lung A. P. Zhiyanov, M. Yu. Shkurnikov
41 [GO] 2023―Mrz―09 Pro-and Antioxidant Status in Newborn with COVID-19 L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, et al. (+2)
42 [GO] 2023―Feb―22 Search for single-domain antibodies interacting with the receptor-binding domain of SARS-CoV-2 surface protein V. S. Aripov, N. V. Volkova, A. V. Taranin, L. V. Mechetina, N. A. Chikaev, A. M. Nayakshin, et al. (+7)
43 [GO] 2023―Jan―04 Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19 M. B. Borgoyakova, L. I. Karpenko, I. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, et al. (+12)
44 [GO] 2022―Nov―04 Quantitative Assay of SARS-CoV-2 RNA and Level of Proinflammatory Protein Gene Transcripts in Peripheral Blood Leukocytes after a Novel Coronavirus Infection L. V. Topchieva, O. V. Balan, A. V. Men’shenin, I. E. Malysheva, E. L. Tikhonovich
45 [GO] 2022―Nov―02 Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19 S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, et al. (+13)
46 [GO] 2022―Okt―25 Pro- and antioxidant status in newborn with COVID-19 L. V. Rychkova, M. A. Darenskaya, A. G. Petrova, N. V. Semenova, E. V. Moskaleva, S. I. Kolesnikov, et al. (+2)
47 [GO] 2022―Okt―10 Changes in Spermatogenesis, Lipoperoxidation Processes, and Antioxidant Protection in Men with Pathozoospermia after COVID-19. The Effectiveness of Correction with a Promising Antioxidant Complex N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kasyanov, et al. (+3)
48 [GO] 2022―Sep―05 Mild or Moderate COVID-19 during Pregnancy Does Not Affect the Content of CD34+ Hematopoietic Stem Cells in Umbilical Cord Blood of Newborns Yu. A. Romanov, Yu. A. Kosolapova, V. V. Zubkov, D. N. Degtyarev, A. Yu. Romanov, T. N. Dugina, G. T. Sukhikh
49 [GO] 2022―Sep―05 Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension D. S. Shilin, K. G. Shapovalov
50 [GO] 2022―Sep―05 Cell and Organism Technologies for Assessment of the SARS-CoV-2 Infectivity in Fluid Environment A. A. Shelemba, E. A. Kazachkova, Yu. V. Kononova, E. I. Kazachinskaya, M. Yu. Rukavishnikov, I. N. Kuvshinova, et al. (+3)
51 [GO] 2022―Aug―29 The immunogenicity of the DNA/protein combinated vaccine against COVID-19 M. B. Borgoyakova, L. I. Karpenko, Yu. A. Merkulyeva, D. N. Shcherbakov, A. P. Rudometov, E. V. Starostina, et al. (+12)
52 [GO] 2022―Jul―01 Features of the humoral response to infection, vaccination, and revaccination during Covid-19 S. Yu. Kombarova, A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, A. M. Zatevalov, E. R. Mekhtiev, et al. (+13)
53 [GO] 2022―Jul―01 Quantitative assessment of SARS-CoV-2 RNA and level of pro-inflammatory protein gene transcripts in PBMC after a novel coronavirus infection L. V. Topchieva, O. V. Balan, A. V. Men'shenin, I. E. Malysheva, E. L. Tikhonovich
54 [GO] 2022―Jun―23 Development of a Test System to Detect the Omicron Variant of SARS-CoV-2 and the Frequency of Its Detection in Patients M. L. Filipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, et al. (+8)
55 [GO] 2022―Jun―06 Changes in spermatogenesis, lipoperoxidation processes and antioxidant protection in men with pathozoospermia after COVID-19 infection. The effectiveness of correction with a promising antioxidant complex N. A. Kurashova, B. G. Dashiev, S. I. Kolesnikov, P. S. Dmitrenok, E. P. Kozlovskaya, S. P. Kas'yanov, et al. (+3)
56 [GO] 2022―Mai―28 Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects N. N. Sushentseva, O. S. Popov, I. A. Polkovnikova, S. V. Al’pako, S. G. Shcherbak
57 [GO] 2022―Mai―27 Morphofunctional Characteristics of Erythrocytes and Blood Erythropoietin Level in Patients as Predictors of Severe Course of COVID-19 V. V. Revin, L. A. Balykova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, et al. (+2)
58 [GO] 2022―Mai―27 Superoxide Dismutase Activity in Male and Female Patients of Different Age with Moderate COVID-19 N. V. Semenova, L. V. Rychkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, et al. (+2)
59 [GO] 2022―Mai―27 Peculiarities of Humoral Immunity Formation in Medical Institution Employees Recovered from or Vaccinated against COVID-19 in Irkutsk V. I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, et al. (+2)
60 [GO] 2022―Mai―02 Reduced Counts of Various Subsets of Peripheral Blood T Lymphocytes in Patients with Severe Course of COVID-19 C. Zhao, X. Hu, Q. Xue, L. Chen
61 [GO] 2022―Apr―28 Changes in some vascular biomarkers in patients with severe COVID-19 with various degrees of pulmonary hypertension D. S. Shilin, K. G. Shapovalov
62 [GO] 2022―Feb―24 Development of a test system to detect the omicron variant of SARS-CoV-2 and the frequency of its detection in patients M. L. Philipenko, I. P. Oskorbin, D. V. Shamovskaya, E. A. Kharpov, A. A. Stepanov, V. V. Romanov, et al. (+8)
63 [GO] 2022―Jan―25 Morphofunctional characteristics of erythrocytes and blood erythropoietin level in patients as predictors of severe COVID-19 V. V. Revin, L. A. Balikova, O. A. Radaeva, V. V. Shchapov, E. S. Revina, S. I. Pinyaev, et al. (+2)
64 [GO] 2022―Jan―25 Superoxide dismutase activity in patients of different sex and age with middle severity COVID-19 N. V. Semenova, L. V. Richkova, M. A. Darenskaya, S. I. Kolesnikov, O. A. Nikitina, A. G. Petrova, et al. (+2)
65 [GO] 2022―Jan―25 Peculiarities of humoral immunity formation among medical institution employees that have been recover or vaccinated against COVID-19 in Irkutsk V .I. Dubrovina, D. D. Bryukhova, N. O. Kiseleva, M. V. Chesnokova, K. M. Korytov, A. B. Pyatidesyatnikova, et al. (+2)
66 [GO] 2022―Jan―08 The Role of Na+/K+-ATPase in the Development of Hyponatrenemia under Conditions of Hypoxic Stress in Patients with SARS-CoV-2 Infection S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar
67 [GO] 2021―Nov―18 Morphometric Parameters of Placental Villi in Parturient Women with COVID-19 A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh
68 [GO] 2021―Nov―18 Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2 P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleinik, G. I. Baikalov
69 [GO] 2021―Nov―17 Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkova, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, et al. (+4)
70 [GO] 2021―Sep―30 The role of Na+/K+-ATPase in the development of hyponatrenemia under hypoxic stress in patients with SARS-CoV-2 S. H. Jafarova, S. A. Adnaev, R. T. Guliyeva, N. H. Jafar
71 [GO] 2021―Sep―20 The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19 B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts
72 [GO] 2021―Aug―02 Increased numbers of syncytial knots and high VEGF expression levels in placental villi among parturient women with COVID-19 depend on the disease severity A. I. Shchegolev, G. V. Kulikova, U. N. Tumanova, R. G. Shmakov, G. T. Sukhikh
73 [GO] 2021―Aug―02 Development of a purified viral preparation for research of COVID-19 (SARS-CoV-2) biology A. A. Chepurnov, E. I. Kazachinskaya, E. A. Kazachkov, K. A. Sharshov, Yu. V. Kononova, A. A. Shelemba, et al. (+4)
74 [GO] 2021―Aug―02 Evaluation of the anti-viral activity of the human recombinant interferon lambda-1 against SARS-CoV-2 P. G. Madonov, V. A. Svyatchenko, S. S. Legostaev, N. A. Kikhtenko, A. A. Kotlyarova, L. A. Oleynik, G. I. Baykalov
75 [GO] 2021―Jul―22 The Number of Syncytial Knots and VEGF Expression in Placental Villi in Parturient Woman with COVID-19 Depends on the Disease Severity A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh
76 [GO] 2021―Jun―26 Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Yu. Kombarova, Yu. S. Lebedin, A. M. Vorob’ev, et al. (+4)
77 [GO] 2021―Apr―27 The state of microcirculatory hemodynamics in patients with moderate and severe COVID-19 B. I. Kuznik, Yu. N. Smolyakov, Yu. K. Shapovalov, K. G. Shapovalov, S. A. Lukyanov, D. S. Parts
78 [GO] 2021―Mrz―22 The number of syncytial knots and VEGF expression in placental villi among parturient women with COVID-19 depends on the disease severity A. I. Shchegolev, G. V. Kulikova, V. M. Lyapin, R. G. Shmakov, G. T. Sukhikh
79 [GO] 2021―Feb―16 Dynamics of antibodies to various antigens of the SARS-CoV-2 coronavirus in patients with confirmed COVID-19 infection A. V. Aleshkin, L. I. Novikova, S. S. Bochkareva, S. Iu. Kombarova, Iu. S. Lebedin, A. M. Vorobev, et al. (+4)
 [1] 

79 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec